Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
Conditions: Lung Cancer Interventions: Other: Usual Care; Behavioral: Brief Patient Education; Behavioral: Patient education; Behavioral: Referral to financial navigation resources; Behavioral: Patient Reminders; Behavioral: Provider Reminders Sponsors: University of California, Irvine; Radiological Society of North America Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Gilteritinib for the Treatment of ALK NSCLC
Conditions: Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8 Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography; Drug: Gilteritinib; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration Sponsors: University of Michigan Rogel Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer Interventions: Drug: ABSK112 Sponsors: Abbisko Therapeutics Co, Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
Conditions: Extensive-stage Small-cell Lung Cancer Interventions: Radiation: Thoracic Radiochemotherapy; Drug: durvalumab; Radiation: Stereotactic radiotherapy of further tumor locations; Drug: Chemotherapy Sponsors: Universit ät des Saarlandes Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
CTS2190 Phase I Clinical Study in Patients
Conditions: Solid Tumors; Pancreatic Cancer; Non-small Cell Lung Cancer Interventions: Drug: CTS2190 capsules Sponsors: CytosinLab Therapeutics Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione
Conditions: Non-Small Cell Lung Cancer Interventions: Behavioral: routine health education; Behavioral: psychological nursing; Behavioral: MBSR therapy; Behavioral: exercise therapy Sponsors: Shanxi Bethune Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Pilot to Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects
Conditions: Non Small Cell Lung Cancer Interventions: Diagnostic Test: Microbiome Sponsors: University of California, Irvine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Neoadjuvant Sintilimab Plus Anlotinib Therapy in IB-IIIB Resectable Non-small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung Interventions: Drug: Sintilimab; Drug: Anlotinib Sponsors: Ningbo No.2 Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
Conditions: Advanced Non-small Cell Lung Cancer; EGFR Mutation; HER2 Mutation; Healthy Volunteers Interventions: Drug: BAY2927088 coated tablet 10 mg; Drug: [14C]-BAY2927088 solution for infusion; Drug: [14C]-BAY2927088 oral solution Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Lung_Cancer_adaptive - Ethos
Conditions: Lung Cancer Interventions: Radiation: online-adaptive radiotherapy Sponsors: University Hospital, Essen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials
Association of Psychological Distress in Patients With Lung Cancer
Conditions: Lung Neoplasms; Psychological Distress; Prognosis Factors; Lifestyle, Healthy; IMMUNOTHERAPY; Targeted Molecular Therapy Interventions: Drug: immunotherapy; Drug: Targeted Therapy Agent Sponsors: Shanghai Chest Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Targeting ODC as an Immunotherapeutic Target in STK11 (LKB1) Pathway-Deficient NSCLC (DFMO)
Conditions: Non Small Cell Lung Cancer; Lung Cancer Interventions: Drug: Pembrolizumab; Drug: Difluoromethylornithine Sponsors: H. Lee Moffitt Cancer Center and Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
A Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation
Conditions: Non-small Cell Lung Cancer; Colorectal Carcinoma; Pancreatic Ductal Adenocarcinoma; Endometrial Cancer; Solid Tumor, Adult; KRAS G12D Interventions: Biological: NT-112: Autologous, engineered T Cells targeting KRAS G12D Sponsors: Neogene Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
DNA Methylation Combined With Artificial Intelligence Imaging to Identify Lung Nodules
Conditions: Lung Cancer Diagnosis Interventions: Diagnostic Test: DNA methylation joint AI imaging Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC
Conditions: Lung Cancer; Extensive-stage Small-cell Lung Cancer Interventions: Radiation: Low-dose radiotherapy; Drug: Etoposide; Drug: Cisplatin; Drug: Sugemalimab; Drug: Olaparib Sponsors: Sichuan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
